SYNAPS Dx
BioTech/Drugs - Rockville, Maryland, US
SYNAPS Dx Details
Synaps Dx is dedicated to transforming the diagnosis of Alzheimer’s disease (AD). Operating a CLIA-certified laboratory, we offer DISCERN™, the first commercially available test to accurately detect AD (>95%). Granted Breakthrough Status by the FDA, DISCERN™ provides a convenient, accurate, minimally invasive diagnosis of Alzheimer’s disease. Through analysis of one (1) small in-office skin biopsy provided by a referring physician, SDx offers a reliable and accurate alternative to traditional diagnostic methods. Our diagnostic biomarkers have been confirmed by neuropathological validation (NIH “Gold Standard”).
SYNAPS Dx Technologies
Email Providers
Outlook
Fonts
Google Font API
Other
Google Apps
Hosting
Amazon AWS